Behavioral genetics of affective and anxiety disorders

Current Topics in Behavioral Neurosciences

Volumn 12, Issue , 2012, Pages 463-502

  Domschke, Katharina ^a   Reif, Andreas ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

CNV; Gene environment interaction (GxE); GWAS; Intermediate phenotype; Pharmacogenetics

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BETA1; 4 AMINOBUTYRIC ACID RECEPTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; CORTICOTROPIN RELEASING FACTOR; DIACYLGLYCEROL; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; GLUTAMATE DECARBOXYLASE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NEUROPEPTIDE Y; SEROTONIN TRANSPORTER; TRANSCRIPTION FACTOR SP4; TRYPTOPHAN HYDROXYLASE 2;

ADOPTION; ANXIETY DISORDER; ANXIETY SENSITIVITY INDEX; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR GENETICS; CLINICAL GENETICS; CLINICAL TRIAL (TOPIC); COPY NUMBER VARIATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; META ANALYSIS (TOPIC); MOLECULAR GENETICS; MOOD DISORDER; NONHUMAN; PHARMACOGENETICS; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TWINS; ANIMAL; GENETICS;

ANIMALS; ANXIETY DISORDERS; GENE-ENVIRONMENT INTERACTION; GENETICS, BEHAVIORAL; HUMANS; MOOD DISORDERS;

EID: 84867505601     PISSN: 18663370     EISSN: 18663389     Source Type: Book Series    
DOI: 10.1007/7854_2011_185     Document Type: Article

References (321)

1. Abdolmaleky HM, Cheng KH, Faraone SV et al (2006) Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum Mol Genet 15: 3132-3145
2. Abdolmaleky HM, Zhou JR, Thiagalingam S et al (2008) Epigenetic and pharmacoepigenomic studies of major psychoses and potentials for therapeutics. Pharmacogenomics 9: 1809-1823
3. Abkevich V, Camp NJ, Hensel CH et al (2003) Predisposition locus for major depression at chromosome 12q22-12q23. 2. Am J Hum Genet 73: 1271-1281
4. Alsene K, Deckert J, Sand P et al (2003) Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 28: 1694-1702
5. Altamura AC, Montresor C, Salvadori D et al (2004) Does comorbid subthreshold anxiety affect clinical presentation and treatment response in depression? A preliminary 12-month naturalistic study. Int J Neuropsychopharmacol 7: 481-487
6. Angst J, Cui L, Swendsen J et al (2010) Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication. Am J Psychiatry 167: 1194-1201
7. Antypa N, Van der Does J (2010) Serotonin transporter gene, childhood emotional abuse and cognitive vulnerability to depression. Genes Brain Behav 9: 615-620
8. Appel K, Schwahn C, Mahler J, Schulz A, Spitzer C, Fenske K, Stender J, Barnow S, John U, Teumer A, Biffar R, Nauck M, Völzke H, Freyberger HJ, Grabe HJ (2011) Moderation of adult depression by a polymorphism in the FKBP5 gene and childhood physical abuse in the general population. Neuropsychopharmacology 36(10): 1982-1991
9. Athanasiu L, Mattingsdal M, Kahler AK et al (2010) Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort. J Psychiatr Res 44: 748-753
10. Badner JA, Gershon ES (2002) Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 7: 405-411
11. Baffa A, Hohoff C, Baune BT et al (2010) Norepinephrine and serotonin transporter genes: impact on treatment response in depression. Neuropsychobiology 62: 121-131
12. Bagby RM, Ryder AG, Cristi C (2002) Psychosocial and clinical predictors of response to pharmacotherapy for depression. Rev Psychiatr Neurosci 27: 250-257
13. Bandelow B, Saleh K, Pauls J et al (2010) Insertion/deletion polymorphism in the gene for angiotensin converting enzyme (ACE) in panic disorder: A gender-specific effect? World J Biol Psychiatry 11: 66-70
14. Barnett JH, Smoller JW (2009) The genetics of bipolar disorder. Neuroscience 164: 331-343
15. Baum AE, Akula N, Cabanero M et al (2008a) A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 13: 197-207
16. Baum AE, Hamshere M, Green E et al (2008b) Meta-analysis of two genome-wide association studies of bipolar disorder reveals important points of agreement. Mol Psychiatry 13: 466-467
17. Baune BT, Hohoff C, Roehrs T et al (2008) Serotonin receptor 1A-1019C/G variant: Impact on antidepressant pharmacoresponse in melancholic depression? Neurosci Lett 436: 111-115
18. Bellodi L, Perna G, Caldirola D et al (1998) CO2-induced panic attacks: a twin study. Am J Psychiatry 155: 1184-1188
19. Berrettini WH (2001) Molecular linkage studies of bipolar disorders. Bipolar Disord 3: 276-283
20. Binder EB (2009) The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology 34(Suppl 1): 186-195
21. Binder EB, Bradley RG, Liu W et al (2008) Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 299: 1291-1305
22. Binder EB, Salyakina D, Lichtner P et al (2004) Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet 36: 1319-1325
23. Blaya C, Salum GA, Lima MS et al (2007) Lack of association between the Serotonin Transporter Promoter Polymorphism (5-HTTLPR) and panic disorder: a systematic review and metaanalysis. Behav Brain Funct 3: 41
24. Bochdanovits Z, Verhage M, Smit AB et al (2009) Joint reanalysis of 29 correlated SNPs supports the role of PCLO/Piccolo as a causal risk factor for major depressive disorder. Mol Psychiatry 14: 650-652
25. Bosker FJ, Hartman CA, Nolte IM et al (2011) Poor replication of candidate genes for major depressive disorder using genome-wide association data. Mol Psychiatry 16: 516-532
26. Bradley RG, Binder EB, Epstein MP et al (2008) Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch Gen Psychiatry 65: 190-200
27. Brent D, Melhem N, Ferrell R et al (2010) Association of FKBP5 polymorphisms with suicidal events in the treatment of resistant depression in adolescents (TORDIA) study. Am J Psychiatry 167: 190-197
28. Brocke B, Armbruster D, Muller J et al (2006) Serotonin transporter gene variation impacts innate fear processing: acoustic startle response and emotional startle. Mol Psychiatry 11: 1106-1112
29. Camp NJ, Lowry MR, Richards RL et al (2005) Genome-wide linkage analyses of extended Utah pedigrees identifies loci that influence recurrent, early-onset major depression and anxiety disorders. Am J Med Genet B Neuropsychiatr Genet 135: 85-93
30. Casamassima F, Huang J, Fava M et al (2010) Phenotypic effects of a bipolar liability gene among individuals with major depressive disorder. Am J Med Genet B Neuropsychiatr Genet 153: 303-309
31. Caspi A, Sugden K, Moffitt TE et al (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301: 386-389
32. Chen C, Glatt SJ, Tsuang MT (2008) The tryptophan hydroxylase gene influences risk for bipolar disorder but not major depressive disorder: results of meta-analyses. Bipolar Disord 10: 816-821
33. Chen D, Liu F, Yang C, Liang X, Shang Q, He W, Wang Z (2011) Association between the TPH1A218C polymorphism and risk of mood disorders and alcohol dependence: evidence from the current studies. J Affect Disord (in press)
34. Chen Z, Liu Y, Zhang D (2009) C677T methylenetetrahydrofolate reductase gene polymorphisms in bipolar disorder: an association study in the Chinese population and a meta-analysis of genetic association studies. Neurosci Lett 449: 48-51
35. Childs E, Hohoff C, Deckert J et al (2008) Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 33: 2791-2800
36. Cho HJ, Meira-Lima I, Cordeiro Q et al (2005) Population-based and family-based studies on the serotonin transporter gene polymorphisms and bipolar disorder: a systematic review and meta-analysis. Mol Psychiatry 10: 771-781
37. Choi KH, Higgs BW, Wendland JR et al (2011) Gene expression and genetic variation data implicate PCLO in bipolar disorder. Biol Psychiatry 69: 353-359
38. Cichon S, Muhleisen TW, Degenhardt FA et al (2011) Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet 88: 372-381
39. Cichon S, Winge I, Mattheisen M et al (2008) Brain-specific tryptophan hydroxylase 2 (TPH2): a functional Pro206Ser substitution and variation in the 50-region are associated with bipolar affective disorder. Hum Mol Genet 17: 87-97
40. Clarke H, Flint J, Attwood AS et al (2010) Association of the 5-HTTLPR genotype and unipolar depression: a meta-analysis. Psychol Med 40: 1767-1778
41. Clayton PJ (1990) The comorbidity factor: establishing the primary diagnosis in patients with mixed symptoms of anxiety and depression. J Clin Psychiatry 51: 35-39
42. Clayton PJ, Grove WM, Coryell W et al (1991) Follow-up and family study of anxious depression. Am J Psychiatry 148: 1512-1517
43. Cloninger CR, Van-Erdewegh P, Goate A et al (1998) Anxiety proneness linked to epistatic loci in genome scan of human personality traits. Am J Med Genet 81: 313-317
44. Cohen-Woods S, Craig I, Gaysina D et al (2010) The bipolar association case-control study (BACCS) and meta-analysis: no association with the 5, 10-Methylenetetrahydrofolate reductase gene and bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 153: 1298-1304
45. Craddock N, Sklar P (2009) Genetics of bipolar disorder: successful start to a long journey. Trends Genet 25: 99-105
46. Crowe RR, Goedken R, Samuelson S (2001) Genome wide survey of panic disorder. Am J Med Genet 105: 105-109
47. Crowe RR, Noyes R Jr, Wilson AF (1987) A linkage study of panic disorder. Arch Gen Psychiatry 44: 933-937
48. Crowe RR, Wang Z, Noyes R Jr (1997) Candidate gene study of eight GABAA receptor subunits in panic disorder. Am J Psychiatry 154: 1096-1100
49. Dawson E, Parfitt E, Roberts Q et al (1995) Linkage studies of bipolar disorder in the region of the Darier's disease gene on chromosome 12q23-24. 1. Am J Med Genet 60: 94-102
50. de Graaf R, Bijl RV, Smit F et al (2002) Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands mental health survey and incidence study. Am J Psychiatry 159: 620-629
51. Deckert J, Catalano M, Heils A et al (1997) Functional promoter polymorphism of the human serotonin transporter: lack of association with panic disorder. Psychiatr Genet 7: 45-47
52. Deckert J, Catalano M, Syagailo YV (1999) Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 8: 621-624
53. Deckert J, Nothen MM, Franke P (1998) Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease. Mol Psychiatry 3: 81-85
54. Dickson SP, Wang K, Krantz I (2010) Rare variants create synthetic genome-wide associations. PLoS Biol 8: e1000294
55. Djurovic S, Gustafsson O, Mattingsdal M (2010) A genome-wide association study of bipolar disorder in Norwegian individuals, followed by replication in Icelandic sample. J Affect Disord 126: 312-316
56. Domschke K, Braun M, Ohrmann P et al (2006) Association of the functional-1019C/G 5-HT1A polymorphism with prefrontal and amygdala activation measured with 3T fMRI in panic disorder. Int J Neuropsychopharmacol 9: 349-355
57. Domschke K, Dannlowski U (2010) Imaging genetics of anxiety disorders. Neuroimage 53(3): 822-831
58. Domschke K, Zwanzger P (2008) GABAergic and endocannabinoid dysfunction in anxiety-future therapeutic targets? Curr Pharm Des 14: 3508-3517
59. Domschke K, Dannlowski U, Hohoff C (2010) Neuropeptide Y (NPY) gene: impact on emotional processing and treatment response in anxious depression. Eur Neuropsychopharmacol 20: 301-309
60. Domschke K, Dannlowski U, Ohrmann P (2008a) Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in major depression. Eur Neuropsychopharmacol 18: 751-759
61. Domschke K, Deckert J, O'Donovan MC (2007) Meta-analysis of COMT val158met in panic disorder: ethnic heterogeneity and gender specificity. Am J Med Genet B Neuropsychiatr Genet 144: 667-673
62. Domschke K, Freitag CM, Kuhlenbäumer G (2004) Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women. Int J Neuropsychopharmacol 7: 183-188
63. Domschke K, Hohoff C, Jacob C (2008b) Chromosome 4q31-34 panic disorder risk locus: Association of neuropeptide Y Y5 receptor variants. Am J Med Genet B Neuropsychiatr Genet 147B: 510-516
64. Domschke K, Hohoff C, Mortensen LS (2008c) Monoamine oxidase A variant influences antidepressant treatment response in female patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry 32: 224-228
65. Domschke K, Kuhlenbaumer G, Schirmacher A (2003) Human nuclear transcription factor gene CREM: genomic organization, mutation screening, and association analysis in panic disorder. Am J Med Genet B Neuropsychiatr Genet 117: 70-78
66. Domschke K, Ohrmann P, Braun M et al (2008d) Influence of the catechol-O-methyltransferase val158met genotype on amygdala and prefrontal cortex emotional processing in panic disorder. Psychiatry Res 163: 13-20
67. Domschke K, Reif A, Weber H, Richter J, Hohoff C, Ohrmann P, Pedersen A, Bauer J, Suslow T, Kugel H, Heindel W, Baumann C, Klauke B, Jacob C, Maier W, Fritze J, Bandelow B, Krakowitzky P, Rothermundt M, Erhardt A, Binder EB, Holsboer F, Gerlach AL, Kircher T, Lang T, Alpers GW, Ströhle A, Fehm L, Gloster AT, Wittchen HU, Arolt V, Pauli P, Hamm A, Deckert J (2011) Neuropeptide S receptor gene-converging evidence for a role in panic disorder. Mol Psychiatry 16(9): 938-948
68. Domschke K, Stevens S, Beck B (2009) Blushing propensity in social anxiety disorder: influence of serotonin transporter gene variation. J Neural Transm 116: 663-666
69. Duman RS, Monteggia LM (2006) A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59: 1116-1127
70. Egeland JA, Gerhard DS, Pauls DL (1987) Bipolar affective disorders linked to DNA markers on chromosome 11. Nature 325: 783-787
71. Erhardt A, Czibere L, Roeske D, Lucae S, Unschuld PG, Ripke S, Specht M, Kohli MA, Kloiber S, Ising M, Heck A, Pfister H, Zimmermann P, Lieb R, Pütz B, Uhr M, Weber P, Deussing JM, Gonik M, Bunck M, Kebler MS, Frank E, Hohoff C, Domschke K, Krakowitzky P, Maier W, Bandelow B, Jacob C, Deckert J, Schreiber S, Strohmaier J, Nöthen M, Cichon S, Rietschel M, Bettecken T, Keck ME, Landgraf R, Müller-Myhsok B, Holsboer F, Binder EB (2011) TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. Mol Psychiatry 16(6): 647-663
72. Erhardt A, Lucae S, Kern N et al (2008) Association of polymorphisms in the angiotensinconverting enzyme gene with syndromal panic attacks. Mol Psychiatry 13: 242-243
73. Erk S, Meyer-Lindenberg A, Schnell K et al (2010) Brain function in carriers of a genome-wide supported bipolar disorder variant. Arch Gen Psychiatry 67: 803-811
74. Ewald H, Degn B, Mors O et al (1998) Significant linkage between bipolar affective disorder and chromosome 12q24. Psychiatr Genet 8: 131-140
75. Ewald H, Flint T, Kruse TA et al (2002) A genome-wide scan shows significant linkage between bipolar disorder and chromosome 12q24. 3 and suggestive linkage to chromosomes 1p22-21, 4p16, 6q14-22, 10q26 and 16p13. 3. Mol Psychiatry 7: 734-744
76. Fan J, Sklar P (2008) Genetics of bipolar disorder: focus on BDNF Val66Met polymorphism. Novartis Found Symp 289: 60-72; discussion 72-63, 87-93
77. Fan M, Liu B, Jiang T et al (2010) Meta-analysis of the association between the monoamine oxidase-A gene and mood disorders. Psychiatr Genet 20: 1-7
78. Fava M, Davidson KG (1996) Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am 19: 179-200
79. Fava M, Rush AJ, Alpert JE (2008) Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry 165: 342-351
80. Ferreira MA, O'Donovan MC, Meng YA et al (2008) Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 40: 1056-1058
81. Fiedorowicz JG, Endicott J, Leon AC (2011) Subthreshold hypomanic symptoms in progression from unipolar major depression to bipolar disorder. Am J Psychiatry 168: 40-48
82. Franchini L, Serretti A, Gasperini M et al (1998) Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees. J Psychiatr Res 32: 255-259
83. Franke B, Vasquez AA, Veltman JA, Brunner HG, Rijpkema M, Fernández G (2010) Genetic variation in CACNA1C, a gene associated with bipolar disorder, influences brainstem rather than gray matter volume in healthy individuals. Biol Psychiatry 68(6): 586-588
84. Freitag CM, Domschke K, Rothe C et al (2006) Interaction of serotonergic and noradrenergic gene variants in panic disorder. Psychiatr Genet 16: 59-65
85. Furlong RA, Ho L, Walsh C et al (1998) Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. Am J Med Genet 81: 58-63
86. Furmark T, Appel L, Henningsson S et al (2008) A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety. J Neurosci 28: 13066-13074
87. Furmark T, Henningsson S, Appel L (2009) Genotype over-diagnosis in amygdala responsiveness: affective processing in social anxiety disorder. J Psychiatry Neurosci 34: 30-40
88. Furmark T, Tillfors M, Garpenstrand H et al (2004) Serotonin transporter polymorphism related to amygdala excitability and symptom severity in patients with social phobia. Neurosci Lett 362: 189-192
89. Fyer AJ, Hamilton SP, Durner M (2006) A third-pass genome scan in panic disorder: evidence for multiple susceptibility loci. Biol Psychiatry 60: 388-401
90. Garriock HA, Hamilton SP (2009a) Genetic studies of drug response and side effects in the STAR*D study, part 1. J Clin Psychiatry 70: 1186-1187
91. Garriock HA, Hamilton SP (2009b) Genetic studies of drug response and side effects in the STAR*D study, part 2. J Clin Psychiatry 70: 1323-1325
92. Gaysina D, Cohen S, Craddock N et al (2008) No association with the 5, 10-methylenetetrahydrofolate reductase gene and major depressive disorder: results of the depression case control (DeCC) study and a meta-analysis. Am J Med Genet B Neuropsychiatr Genet 147B: 699-706
93. Gelernter J, Bonvicini K, Page G et al (2001) Linkage genome scan for loci predisposing to panic disorder or agoraphobia. Am J Med Genet 105: 548-557
94. Gelernter J, Page GP, Bonvicini K et al (2003) A chromosome 14 risk locus for simple phobia: results from a genomewide linkage scan. Mol Psychiatry 8: 71-82
95. Gelernter J, Page GP, Stein MB et al (2004) Genome-wide linkage scan for loci predisposing to social phobia: evidence for a chromosome 16 risk locus. Am J Psychiatry 161: 59-66
96. Gershon ES, Alliey-Rodriguez N, Liu C (2011) After GWAS: searching for genetic risk for schizophrenia and bipolar disorder. Am J Psychiatry 168: 253-256
97. Gilbody S, Lewis S, Lightfoot T (2007) Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. Am J Epidemiol 165: 1-13
98. Goldstein RB, Wickramaratne PJ, Horwath E (1997) Familial aggregation and phenomenology of 'early'-onset (at or before age 20 years) panic disorder. Arch Gen Psychiatry 54: 271-278
99. Green E, Elvidge G, Jacobsen N et al (2005) Localization of bipolar susceptibility locus by molecular genetic analysis of the chromosome 12q23-q24 region in two pedigrees with bipolar disorder and Darier's disease. Am J Psychiatry 162: 35-42
100. Green EK, Grozeva D, Jones I et al (2009) The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol Psychiatry 15: 1016-1022
101. Grigoroiu-Serbanescu M, Diaconu CC, Herms S et al (2008) Investigation of the tryptophan hydroxylase 2 gene in bipolar I disorder in the Romanian population. Psychiatr Genet 18: 240-247
102. Grozeva D, Kirov G, Ivanov D et al (2010) Rare copy number variants: a point of rarity in genetic risk for bipolar disorder and schizophrenia. Arch Gen Psychiatry 67: 318-327
103. Gunthert KC, Conner TS, Armeli S et al (2007) Serotonin transporter gene polymorphism (5-HTTLPR) and anxiety reactivity in daily life: a daily process approach to gene-environment interaction. Psychosom Med 69: 762-768
104. Halmoy A, Johansson S, Winge I et al (2010) Attention-deficit/hyperactivity disorder symptoms in offspring of mothers with impaired serotonin production. Arch Gen Psychiatry 67: 1033-1043
105. Hamilton SP, Fyer AJ, Durner M et al (2003) Further genetic evidence for a panic disorder syndrome mapping to chromosome 13q. Proc Natl Acad Sci USA 100: 2550-2555
106. Hamilton SP, Heiman GA, Haghighi F et al (1999) Lack of genetic linkage or association between a functional serotonin transporter polymorphism and panic disorder. Psychiatr Genet 9: 1-6
107. Hamilton SP, Slager SL, de Baisre LA et al (2004a) Evidence for genetic linkage between a polymorphism in the adenosine 2A receptor and panic disorder. Neuropsychopharmacology 29: 558-565
108. Hamilton SP, Slager SL, Heiman GA et al (2002) Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22. Biol Psychiatry 51: 591-601
109. Hamilton SP, Slager SL, Mayo D (2004b) Investigation of polymorphisms in the CREM gene in panic disorder. Am J Med Genet B Neuropsychiatr Genet 126: 111-115
110. Hasler G, Drevets WC, Manji HK et al (2004) Discovering endophenotypes for major depression. Neuropsychopharmacology 29: 1765-1781
111. Hattori E, Ebihara M, Yamada K et al (2001) Identification of a compound short tandem repeat stretch in the 50-upstream region of the cholecystokinin gene, and its association with panic disorder but not with schizophrenia. Mol Psychiatry 6: 465-470
112. Hattori E, Toyota T, Ishitsuka Y et al (2009) Preliminary genome-wide association study of bipolar disorder in the Japanese population. Am J Med Genet B Neuropsychiatr Genet 150B: 1110-1117
113. Hek K, Mulder CL, Luijendijk HJ et al (2010) The PCLO gene and depressive disorders: replication in a population-based study. Hum Mol Genet 19: 731-734
114. Hettema JM (2008) What is the genetic relationship between anxiety and depression? Am J Med Genet C Semin Med Genet 148C: 140-146
115. Hettema JM, An SS, Neale MC et al (2006) Association between glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism. Mol Psychiatry 11: 752-762
116. Hettema JM, Neale MC, Kendler KS (2001) A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 158: 1568-1578
117. Ho HP, Westberg L, Annerbrink K (2004) Association between a functional polymorphism in the progesterone receptor gene and panic disorder inwomen. Psychoneuroendocrinology 2: 1138-1141
118. Hodges LM, Weissman MM, Haghighi F (2009) Association and linkage analysis of candidate genes GRP, GRPR, CRHR1, and TACR1 in panic disorder. Am J Med Genet B Neuropsychiatr Genet 150: 65-73
119. Hohoff C, Domschke K, Schwarte K et al (2009a) Sympathetic activity relates to adenosine A(2A) receptor gene variation in blood-injury phobia. J Neural Transm 116: 659-662
120. Hohoff C, Mullings EL, Heatherley SV, Freitag CM, Neumann LC, Domschke K, Krakowitzky P, Rothermundt M, Keck ME, Erhardt A, Unschuld PG, Jacob C, Fritze J, Bandelow B, Maier W, Holsboer F, Rogers PJ, Deckert J (2010) Adenosine A(2A) receptor gene: evidence for association of risk variants with panic disorder and anxious personality. J Psychiatr Res 44(14): 930-937
121. Hohoff C, Neumann A, Domschke K et al (2009b) Association analysis of Rgs7 variants with panic disorder. J Neural Transm 116: 1523-1528
122. Horstmann S, Lucae S, Menke A et al (2010) Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment. Neuropsychopharmacology 35: 727-740
123. Horwath E, Adams P, Wickramaratne P et al (1997) Panic disorder with smothering symptoms: evidence for increased risk in first-degree relatives. Depress Anxiety 6: 147-153
124. Horwath E, Wolk SI, Goldstein RB et al (1995) Is the comorbidity between social phobia and panic disorder due to familial cotransmission or other factors? Arch Gen Psychiatry 52: 574-582
125. Hösing VG, Schirmacher A, Kuhlenbäumer G, Freitag C, Sand P, Schlesiger C, Jacob C, Fritze J, Franke P, Rietschel M, Garritsen H, Nöthen MM, Fimmers R, Stögbauer F, Deckert J (2004) Cholecystokinin-and cholecystokinin-B-receptor gene polymorphisms in panic disorder. J Neural Transm Suppl 68: 147-156
126. Huang J, Perlis RH, Lee PH, Rush AJ, Fava M, Sachs GS, Lieberman J, Hamilton SP, Sullivan P, Sklar P, Purcell S, Smoller JW (2010) Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression. Am J Psychiatry 167(10): 1254-1263
127. Huang YY, Battistuzzi C, Oquendo MA et al (2004) Human 5-HT1A receptor C(-1019)G polymorphism and psychopathology. Int J Neuropsychopharmacol 7: 441-451
128. Inada Y, Yoneda H, Koh J et al (2003) Positive association between panic disorder and polymorphism of the serotonin 2A receptor gene. Psychiatry Res 118: 25-31
129. Ising M, Lucae S, Binder EB et al (2009) A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. Arch Gen Psychiatry 66: 966-975
130. Joffe RT, Bagby RM, Levitt A (1993) Anxious and nonanxious depression. Am J Psychiatry 150: 1257-1258
131. Jones I, Jacobsen N, Green EK et al (2002) Evidence for familial cosegregation of major affective disorder and genetic markers flanking the gene for Darier's disease. Mol Psychiatry 7: 424-427
132. Kaabi B, Gelernter J, Woods SW et al (2006) Genome scan for loci predisposing to anxiety disorders using a novel multivariate approach: strong evidence for a chromosome 4 risk locus. Am J Hum Genet 78: 543-553
133. Kanazawa T, Glatt SJ, Kia-Keating B et al (2007) Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder. Psychiatr Genet 17: 165-170
134. Kang EH, Song YJ, Kim KJ et al (2010) Sympathetic nervous function and the effect of the catechol-O-methyltransferase Val(158)Met polymorphism in patients with panic disorder. J Affect Disord 123: 337-340
135. Karg K, Burmeister M, Shedden K et al (2011) The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch Gen Psychiatry 68: 444-454
136. Keers R, Farmer AE, Aitchison KJ (2009) Extracting a needle from a haystack: reanalysis of whole genome data reveals a readily translatable finding. Psychol Med 39: 1231-1235
137. Kato M, Serretti A (2010) Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol Psychiatry 15: 473-500
138. Keck ME, Kern N, Erhardt A et al (2008) Combined effects of exonic polymorphisms in CRHR1 and AVPR1B genes in a case/control study for panic disorder. Am J Med Genet B Neuropsychiatr Genet 147B: 1196-1204
139. Kempton MJ, Ruberto G, Vassos E et al (2009) Effects of the CACNA1C risk allele for bipolar disorder on cerebral gray matter volume in healthy individuals. Am J Psychiatry 166: 1413-1414
140. Kendler KS (1996) Major depression and generalised anxiety disorder. Same genes, (partly) different environments-revisited. Br J Psychiatry 30: 68-75
141. Kendler KS, Gardner CO, Gatz M et al (2007) The sources of co-morbidity between major depression and generalized anxiety disorder in a Swedish national twin sample. Psychol Med 37: 453-462
142. Kendler KS, Karkowski LM, Prescott CA (1999) Fears and phobias: reliability and heritability. Psychol Med 29: 539-553
143. Kendler KS, Neale MC, Kessler RC et al (1992) Major depression and generalized anxiety disorder. Same genes, (partly) different environments? Arch Gen Psychiatry 49: 716-722
144. Kendler KS, Walters EE, Neale MC et al (1995) The structure of the genetic and environmental risk factors for six major psychiatric disorders in women. Arch Gen Psychiatry 52: 374-383
145. Kennedy JL, Bradwejn J, Koszycki D et al (1999) Investigation of cholecystokinin system genes in panic disorder. Mol Psychiatry 4: 284-285
146. Kessler RC, Nelson CB, McGonagle KA (1996) Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry Suppl 30: 17-30
147. Kim YK, Lee HJ, Yang JC et al (2009) A tryptophan hydroxylase 2 gene polymorphism is associated with panic disorder. Behav Genet 39: 170-175
148. Kirchheiner J, Nickchen K, Bauer M et al (2004) Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response. Mol Psychiatry 9: 442-473
149. Kishi T, Okochi T, Tsunoka T et al (2011) Serotonin 1A receptor gene, schizophrenia and bipolar disorder: an association study and meta-analysis. Psychiatry Res 185: 20-26
150. Klauke B, Deckert J, Reif A et al (2010) Life events in panic disorder-An update on ''candidate stressors''. Depress Anxiety 27: 716-730
151. Knowles JA, Fyer AJ, Vieland VJ et al (1998) Results of a genome-wide genetic screen for panic disorder. Am J Med Genet 81: 139-147
152. Kobayashi Y, Akiyoshi J, Kanehisa M et al (2007) Lack of polymorphism in genes encoding mGluR 7, mGluR 8, GABA(A) receptor alfa-6 subunit and nociceptin/orphanin FQ receptor and panic disorder. Psychiatr Genet 17: 9
153. Krug A, Nieratschker V, Markov V et al (2010) Effect of CACNA1C rs1006737 on neural correlates of verbal fluency in healthy individuals. Neuroimage 49: 1831-1836
154. Laje G, Allen AS, Akula N et al (2009) Genome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatients. Pharmacogenet Genomics 19: 666-674
155. Lango Allen H, Estrada K, Lettre G et al (2010) Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 467: 832-838
156. Lasky-Su JA, Faraone SV, Glatt SJ et al (2005) Meta-analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders. Am J Med Genet B Neuropsychiatr Genet 133B: 110-115
157. Laucht M, Treutlein J, Blomeyer D et al (2009) Interaction between the 5-HTTLPR serotonin transporter polymorphism and environmental adversity for mood and anxiety psychopathology: evidence from a high-risk community sample of young adults. Int J Neuropsychopharmacol 12: 737-747
158. Lavebratt C, Aberg E, Sjoholm LK et al (2010) Variations in FKBP5 and BDNF genes are suggestively associated with depression in a Swedish population-based cohort. J Affect Disord 125: 249-255
159. Leckman JF, Weissman MM, Merikangas KR et al (1983) Panic disorder and major depression. Increased risk of depression, alcoholism, panic, and phobic disorders in families of depressed probands with panic disorder. Arch Gen Psychiatry 40: 1055-1060
160. Lee MT, Chen CH, Lee C et al (2010) Genome-wide association study of bipolar I disorder in the Han Chinese population. Mol Psychiatry 16: 548-556
161. Lee YJ, Hohoff C, Domschke K et al (2005) Norepinephrine transporter (NET) promoter and 50-UTR polymorphisms: association analysis in panic disorder. Neurosci Lett 377: 40-43
162. Lekman M, Laje G, Charney D et al (2008) The FKBP5-gene in depression and treatment response-an association study in the sequenced treatment alternatives to relieve depression (STAR*D) cohort. Biol Psychiatry 63: 1103-1110
163. Lesch K, Bengel D, Heils A et al (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274: 1527-1531
164. Lesch KP, Timmesfeld N, Renner TJ et al (2008) Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. J Neural Transm 115: 1573-1585
165. Levine J, Cole DP, Chengappa KN et al (2001) Anxiety disorders and major depression, together or apart. Depress Anxiety 14: 94-104
166. Lewis CM, Ng MY, Butler AW et al (2010) Genome-wide association study of major recurrent depression in the U. K. population. Am J Psychiatry 167: 949-957
167. Leygraf A, Hohoff C, Freitag C et al (2006) Rgs 2 gene polymorphisms as modulators of anxiety in humans? J Neural Transm 113: 1921-1925
168. Lichtenstein P, Yip BH, Bjork C et al (2009) Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 373: 234-239
169. Liebowitz MR (1993) Depression with anxiety and a typical depression. J Clin Psychiatry 54: 10-14
170. Liu Y, Blackwood DH, Caesar S et al (2011) Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. Mol Psychiatry 16: 2-4
171. Lochner C, Hemmings S, Seedat S et al (2007) Genetics and personality traits in patients with social anxiety disorder: a case-control study in South Africa. Eur Neuropsychopharmacol 17: 321-327
172. Logue MW, Durner M, Heiman GA et al (2009) A linkage search for joint panic disorder/bipolar genes. Am J Med Genet B Neuropsychiatr Genet 150: 1139-1146
173. Lohoff FW (2010) Overview of the genetics of major depressive disorder. Curr Psychiatry Rep 12: 539-546
174. Lopez-Leon S, Janssens AC, Gonzalez-Zuloeta Ladd AM et al (2008) Meta-analyses of genetic studies on major depressive disorder. Mol Psychiatry 13: 772-785
175. Lopez Leon S, Croes EA, Sayed-Tabatabaei FA et al (2005) The dopamine D4 receptor gene 48-base-pair-repeat polymorphism and mood disorders: a meta-analysis. Biol Psychiatry 57: 999-1003
176. Luykx JJ, Boks MP, Terwindt AP et al (2010) The involvement of GSK3beta in bipolar disorder: integrating evidence from multiple types of genetic studies. Eur Neuropsychopharmacol 20: 357-368
177. Lydiard RB (1991) Coexisting depression and anxiety: special diagnostic and treatment issues. J Clin Psychiatry 52: 48-54
178. Lydiard RB, Brawman-Mintzer O (1998) Anxious depression. J Clin Psychiatry 59: 10-17
179. MacGillivray S, Arroll B, Hatcher S et al (2003) Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis. BMJ 326: 1014
180. MacKinnon DF, Xu J, McMahon FJ et al (1998) Bipolar disorder and panic disorder in families: an analysis of chromosome 18 data. Am J Psychiatry 155: 829-831
181. Maier W, Lichtermann D, Minges J et al (1992) Personality traits in subjects at risk for unipolar major depression: a family study perspective. J Affect Disord 24: 153-163
182. Maier W, Lichtermann D, Minges J (1993) A controlled family study in panic disorder. J Psychiatr Res 27: 79-87
183. Manchia M, Squassina A, Congiu D et al (2009) Interacting genes in lithium prophylaxis: preliminary results of an exploratory analysis on the role of DGKH and NR1D1 gene polymorphisms in 199 Sardinian bipolar patients. Neurosci Lett 467: 67-71
184. Marks IM, Herst ER (1970) A survey of 1200 agoraphobics in Britain. Soc Psychiatry 5: 16-24
185. Maron E, Lang A, Tasa G et al (2005a) Associations between serotonin-related gene polymorphisms and panic disorder. Int J Neuropsychopharmacol 8: 261-266
186. Maron E, Nikopensius T, Koks S et al (2005b) Association study of 90 candidate gene polymorphisms in panic disorder. Psychiatr Genet 15: 17-24
187. Maron E, Toru I, Must A et al (2007) Association study of tryptophan hydroxylase 2 gene polymorphisms in panic disorder. Neurosci Lett 411: 180-184
188. Maziade M, Roy MA, Rouillard E et al (2001) A search for specific and common susceptibility loci for schizophrenia and bipolar disorder: a linkage study in 13 target chromosomes. Mol Psychiatry 6: 684-693
189. McCarthy MI, Abecasis GR, Cardon LR et al (2008) Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 9: 356-369
190. McCarthy MJ, Leckband SG, Kelsoe JR (2010) Pharmacogenetics of lithium response in bipolar disorder. Pharmacogenomics 11: 1439-1465
191. McGrath M, Kawachi I, Ascherio A et al (2004) Association between catechol-O-methyltransferase and phobic anxiety. Am J Psychiatry 161: 1703-1705
192. McGuffin P, Knight J, Breen G et al (2005) Whole genome linkage scan of recurrent depressive disorder from the depression network study. Hum Mol Genet 14: 3337-3345
193. McMahon FJ, Akula N, Schulze TG et al (2010) Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21. 1. Nat Genet 42: 128-131
194. McQueen MB, Devlin B, Faraone SV et al (2005) Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. Am J Hum Genet 77: 582-595
195. Mendlewicz J, Rainer JD (1977) Adoption study supporting genetic transmission in manic-depressive illness. Nature 268: 327-329
196. Middeldorp CM, Cath DC, Van Dyck R et al (2005) The co-morbidity of anxiety and depression in the perspective of genetic epidemiology. A review of twin and family studies. Psychol Med 35: 611-624
197. Montag C, Buckholtz JW, Hartmann P et al (2008) COMT genetic variation affects fear processing: psychophysiological evidence. Behav Neurosci 122: 901-909
198. Mosing MA, Gordon SD, Medland SE et al (2009) Genetic and environmental influences on the co-morbidity between depression, panic disorder, agoraphobia, and social phobia: a twin study. Depress Anxiety 26: 1004-1011
199. Moskvina V, Craddock N, Holmans P et al (2009) Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Mol Psychiatry 14: 252-260
200. Mössner R, Freitag CM, Gutknecht L et al (2006) The novel brain-specific tryptophan hydroxylase-2 gene in panic disorder. J Psychopharmacol 20: 547-552
201. Moya PR, Murphy DL, McMahon FJ, Wendland JR (2010) Increased gene expression of diacylglycerol kinase η in bipolar disorder. Int J Neuropsychopharmacol 13(8): 1127-1128
202. Muglia P, Tozzi F, Galwey NW et al (2010) Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts. Mol Psychiatry 15: 589-601
203. Muller DJ, Zai CC, Shinkai T et al (2011) Association between the DAOA/G72 gene and bipolar disorder and meta-analyses in bipolar disorder and schizophrenia. Bipolar Disord 13: 198-207
204. Nakamura K, Yamada K, Iwayama Y et al (2006) Evidence that variation in the peripheral benzodiazepine receptor (PBR) gene influences susceptibility to panic disorder. Am J Med Genet B Neuropsychiatr Genet 141B: 222-226
205. Nelson JC (2008) Anxious depression and response to treatment. Am J Psychiatry 165: 297-299
206. Nelson JC, Delucchi K, Schneider LS (2009) Anxiety does not predict response to antidepressant treatment in late life depression: results of a meta-analysis. Int J Geriatr Psychiatry 24: 539-544
207. Nyegaard M, Demontis D, Foldager L et al (2010) CACNA1C (rs1006737) is associated with schizophrenia. Mol Psychiatry 15: 119-121
208. O'Donovan MC, Craddock N, Norton N et al (2008) Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 40: 1053-1055
209. Ohara K, Nagai M, Suzuki Y et al (1998) Association between anxiety disorders and a functional polymorphism in the serotonin transporter gene. Psychiatry Res 81: 277-279
210. Ollila HM, Soronen P, Silander K et al (2009) Findings from bipolar disorder genome-wide association studies replicate in a Finnish bipolar family-cohort. Mol Psychiatry 14: 351-353
211. Olsson M, Annerbrink K, Westberg L et al (2004) Angiotensin-related genes in patients with panic disorder. Am J Med Genet B Neuropsychiatr Genet 127: 81-84
212. O'Reilly RL, Bogue L, Singh SM (1994) Pharmacogenetic response to antidepressants in a multicase family with affective disorder. Biol Psychiatry 36: 467-471
213. Otowa T, Tanii H, Sugaya N et al (2010) Replication of a genome-wide association study of panic disorder in a Japanese population. J Hum Genet 55: 91-96
214. Otowa T, Yoshida E, Sugaya N et al (2009) Genome-wide association study of panic disorder in the Japanese population. J Hum Genet 54: 122-126
215. Overall JE, Hollister LE, Johnson M et al (1966) Nosology of depression and differential response to drugs. JAMA 195: 946-948
216. Overall JE, Zisook S (1980) Diagnosis and the phenomenology of depressive disorders. J Consult Clin Psychol 48: 626-634
217. Papakostas GI, Stahl SM, Krishen A et al (2008) Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies. J Clin Psychiatry 69: 1287-1292
218. Pare CM, Mack JW (1971) Differentiation of two genetically specific types of depression by the response to antidepressant drugs. J Med Genet 8: 306-309
219. Peerbooms OL, van Os J, Drukker M, Kenis G, Hoogveld L, MTHFR in Psychiatry Group, de Hert M, Delespaul P, van Winkel R, Rutten BP (2011) Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: evidence for a common genetic vulnerability? Brain Behav Immun 25(8): 1530-1543
220. Perlis RH, Huang J, Purcell S et al (2010) Genome-wide association study of suicide attempts in mood disorder patients. Am J Psychiatry 167: 1499-1507
221. Perlis RH, Smoller JW, Ferreira MA et al (2009) A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder. Am J Psychiatry 166: 718-725
222. Perna G, Favaron E, DiBella D et al (2005) Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene. Neuropsychopharmacol 30: 2230-2235
223. Perroud N, Uher R, Ng MY, Guipponi M, Hauser J, Henigsberg N, Maier W, Mors O, Gennarelli M, Rietschel M, Souery D, Dernovsek MZ, Stamp AS, Lathrop M, Farmer A, Breen G, Aitchison KJ, Lewis CM, Craig IW, McGuffin P (2010) Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project. Pharmacogenomics J (in press)
224. Pickard BS, Christoforou A, Thomson PA et al (2009) Interacting haplotypes at the NPAS3 locus alter risk of schizophrenia and bipolar disorder. Mol Psychiatry 14: 874-884
225. Poulton R, Andrews G, Millichamp J (2008) Gene-environment interaction and the anxiety disorders. Eur Arch Psychiatry Clin Neurosci 258: 65-68
226. Purcell SM, Wray NR, Stone JL et al (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460: 748-752
227. Ressler KJ, Bradley B, Mercer KB et al (2010) Polymorphisms in CRHR1 and the serotonin transporter loci: gene x gene x environment interactions on depressive symptoms. Am J Med Genet B Neuropsychiatr Genet 153B: 812-824
228. Rietschel M, Mattheisen M, Frank J et al (2010) Genome-wide association-, replication-, and neuroimaging study implicates HOMER1 in the etiology of major depression. Biol Psychiatry 68: 578-585
229. Psychiatric GWAS Consortium (2009) A framework for interpreting genome-wide association studies of psychiatric disorders. Mol Psychiatry 14: 10-17
230. Rosenbaum JF, Biederman J, Hirshfield DR et al (1991) Further evidence of an association between behavioral inhibition and anxiety disorders: results from a family study of children from a non-clinical sample. J Psychiatr Res 25: 49-65
231. Rothe C, Gutknecht L, Freitag C et al (2004) Association of a functional 1019C[G 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia. Int J Neuropsychopharmacol 7: 189-192
232. Rowe DC, Stever C, Gard JM et al (1998) The relation of the dopamine transporter gene (DAT1) to symptoms of internalizing disorders in children. Behav Genet 28: 215-225
233. Roy MA, Neale MC, Pedersen NL et al (1995) A twin study of generalized anxiety disorder and major depression. Psychol Med 25: 1037-1049
234. Rudolph RL, Entsuah R, Chitra R (1998) A meta-analysis of the effects of venlafaxine on anxiety associated with depression. J Clin Psychopharmacol 18: 136-144
235. Samochowiec J, Hajduk A, Samochowiec A et al (2004) Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum. Psychiatry Res 128: 21-26
236. Sand P, Lesch KP, Catalano M et al (2000) Polymorphic MAO-A and 5-HT-transporter genes: analysis of interactions in panic disorder. World J Biol Psychiatry 1: 147-150
237. Sand PG, Mori T, Godau C et al (2002a) Norepinephrine transporter gene (NET) variants in patients with panic disorder. Neurosci Lett 333: 41-44
238. Sand PG, Schlurmann K, Luckhaus C et al (2002b) Estrogen receptor 1 gene (ESR1) variants in panic disorder. Am J Med Genet 114: 426-428
239. Schmidt NB, Storey J, Greenberg BD et al (2000) Evaluating gene x psychological risk factor effects in the pathogenesis of anxiety: a new model approach. J Abnorm Psychol 109: 308-320
240. Scholz CJ, Jacob CP, Buttenschon HN et al (2010) Functional variants of TSPAN8 are associated with bipolar disorder and schizophrenia. Am J Med Genet B Neuropsychiatr Genet 153B(4): 967-972
241. 2-induced fear by 5-HTTLPR genotype. J Psychopharmacol 25(1): 37-42
242. Schulze TG, Alda M, Adli M et al (2010) The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment. Neuropsychobiology 62: 72-78
243. Schulze TG, Detera-Wadleigh SD, Akula N et al (2009) Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder. Mol Psychiatry 14: 487-491
244. Schulze TG, McMahon FJ (2003) Genetic linkage and association studies in bipolar affective disorder: a time for optimism. Am J Med Genet C Semin Med Genet 123C: 36-47
245. Scott LJ, Muglia P, Kong XQ et al (2009) Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry. Proc Natl Acad Sci USA 106: 7501-7506
246. Segman RH, Shalev AY (2003) Genetics of posttraumatic stress disorder. CNS Spectr 8: 693-698
247. Segurado R, Detera-Wadleigh SD, Levinson DF et al (2003) Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet 73: 49-62
248. Serretti A, Artioli P, Quartesan R (2005) Pharmacogenetics in the treatment of depression: pharmacodynamic studies. Pharmacogenet Genom 15: 61-67
249. Serretti A, Mandelli L (2008) The genetics of bipolar disorder: genome 'hot regions', genes, new potential candidates and future directions. Mol Psychiatry 13: 742-771
250. Shi J, Badner JA, Gershon ES et al (2008) Allelic association of G72/G30 with schizophrenia and bipolar disorder: a comprehensive meta-analysis. Schizophr Res 98: 89-97
251. Shi J, Potash JB, Knowles JA et al (2011) Genome-wide association study of recurrent earlyonset major depressive disorder. Mol Psychiatry 16: 193-201
252. Shih RA, Belmonte PL, Zandi PP (2004) A review of the evidence from family, twin and adoption studies for a genetic contribution to adult psychiatric disorders. Int Rev Psychiatry 16: 260-283
253. Shimizu E, Hashimoto K, Kobayashi K et al (2004) Lack of association between angiotensin I-converting enzyme insertion/deletion gene functional polymorphism and panic disorder in humans. Neurosci Lett 363: 81-83
254. Shyn SI, Shi J, Kraft JB et al (2011) Novel loci for major depression identified by genome-wide association study of sequenced treatment alternatives to relieve depression and meta-analysis of three studies. Mol Psychiatry 16: 202-215
255. Silverstone PH, Ravindran A (1999) Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group. J Clin Psychiatry 60: 22-28
256. Silverstone PH, von Studnitz E (2003) Defining anxious depression: going beyond comorbidity. Can J Psychiatry 48: 675-680
257. Sklar P, Smoller JW, Fan J et al (2008) Whole-genome association study of bipolar disorder. Mol Psychiatry 13: 558-569
258. Skre I, Onstad S, Torgersen S (1993) A twin study of DSM-III-R anxiety disorders. Acta Psychiatr Scand 88: 85-92
259. Smith DJ, Evans R, Craddock N (2010) Predicting response to lithium in bipolar disorder: a critical review of pharmacogenetic studies. J Ment Health 19: 142-156
260. Smith EN, Bloss CS, Badner JA et al (2009) Genome-wide association study of bipolar disorder in European American and African American individuals. Mol Psychiatry 14: 755-763
261. Smoller JW, Finn CT (2003) Family, twin, and adoption studies of bipolar disorder. Am J Med Genet C Semin Med Genet 123C: 48-58
262. Smoller JW, Gardner-Schuster E et al (2008a) Genetics of anxiety: would the genome recognize the DSM. Depress Anxiety 25: 368-377
263. Smoller JW, Paulus MP, Fagerness JA et al (2008b) Influence of RGS2 on anxiety-related temperament, personality, and brain function. Arch Gen Psychiatry 65: 298-308
264. Smoller JW, Rosenbaum JF, Biederman J et al (2003) Association of a genetic marker at the corticotropin releasing hormone locus with behavioral inhibition. Biol Psychiatry 54: 1376-1381
265. Smoller JW, Yamaki LH, Fagerness JA et al (2005) The corticotropin releasing hormone gene and behavioral inhibition in children at risk for panic disorder. Biol Psychiatry 57: 1485-1492
266. Soronen P, Ollila HM, Antila M et al (2010) Replication of GWAS of bipolar disorder: association of SNPs near CDH7 with bipolar disorder and visual processing. Mol Psychiatry 15: 4-6
267. Speliotes EK, Willer CJ, Berndt SI et al (2010) Association analyses of 249, 796 individuals reveal 18 new loci associated with body mass index. Nat Genet 42: 937-948
268. Squassina A, Manchia M, Congiu D et al (2009) The diacylglycerol kinase eta gene and bipolar disorder: a replication study in a Sardinian sample. Mol Psychiatry 14: 350-351
269. Stein MB, Chartier MJ, Kozak MV et al (1998) Genetic linkage to the serotonin transporter protein and 5HT2A receptor genes excluded in generalized social phobia. Psychiatry Res 81: 283-291
270. Stein MB, Jang KL, Livesley WJ (1999) Heritability of anxiety sensitivity. Am J Psychiatry 156: 246-251
271. Stein MB, Schork NJ, Gelernter J (2008) Gene-by-environment (serotonin transporter and childhood maltreatment) interaction for anxiety sensitivity, an intermediate phenotype for anxiety disorders. Neuropsychopharmacology 33: 312-319
272. Stein MB, Seedat S, Gelernter J (2006) Serotonin transporter gene promoter polymorphism predicts SSRI response in generalized social anxiety disorder. Psychopharmacology (Berl) 187: 68-72
273. Steinberg S, Mors O, Borglum AD et al (2011) Expanding the range of ZNF804A variants conferring risk of psychosis. Mol Psychiatry 16: 59-66
274. Strug LJ, Suresh R, Fyer AJ et al (2010) Panic disorder is associated with the serotonin transporter gene (SLC6A4) but not the promoter region (5-HTTLPR). Mol Psychiatry 15: 166-176
275. Sullivan PF (2010) The psychiatric GWAS consortium: big science comes to psychiatry. Neuron 68: 182-186
276. Sullivan PF, de Geus EJ, Willemsen G et al (2009) Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Mol Psychiatry 14: 359-375
277. Sullivan PF, Neale MC, Kendler KS (2000) Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 157: 1552-1562
278. Tadic A, Rujescu D, Szegedi A et al (2003) Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression. Am J Med Genet B Neuropsychiatr Genet 117: 1-6
279. Takata A, Kawasaki H, Iwayama Y et al (2011) Nominal association between a polymorphism in DGKH and bipolar disorder detected in a meta-analysis of East Asian case-control samples. Psychiatry Clin Neurosci 65: 280-285
280. Terracciano A, Tanaka T, Sutin AR et al (2010) Genome-wide association scan of trait depression. Biol Psychiatry 68: 811-817
281. Tesli M, Athanasiu L, Mattingsdal M et al (2010) Association analysis of PALB2 and BRCA2 in bipolar disorder and schizophrenia in a scandinavian case-control sample. Am J Med Genet B Neuropsychiatr Genet 153B: 1276-1282
282. Tesli M, Kahler AK, Andreassen BK et al (2009) No association between DGKH and bipolar disorder in a Scandinavian case-control sample. Psychiatr Genet 19: 269-272
283. Thoeringer CK, Binder EB, Salyakina D et al (2007) Association of a Met88Val diazepam binding inhibitor (DBI) gene polymorphism and anxiety disorders with panic attacks. J Psychiatr Res 41: 579-584
284. Thoeringer CK, Ripke S, Unschuld PG et al (2009) The GABA transporter 1 (SLC6A1): a novel candidate gene for anxiety disorders. J Neural Transm 116: 649-657
285. Thomas D (2010) Gene-environment-wide association studies: emerging approaches. Nat Rev Genet 11: 259-272
286. Thorgeirsson TE, Oskarsson H, Desnica N et al (2003) Anxiety with panic disorder linked to chromosome 9q in Iceland. Am J Hum Genet 72: 1221-1230
287. Tsuang M, Domschke K, Jerskey BA et al (2004) Agoraphobic behavior and panic attack: a study of male twins. J Anxiety Disord 18: 799-807
288. Uher R, McGuffin P (2008) The moderation by the serotonin transporter gene of environmental adversity in the aetiology of mental illness: review and methodological analysis. Mol Psychiatry 13: 131-146
289. Uher R, McGuffin P (2010) The moderation by the serotonin transporter gene of environmental adversity in the etiology of depression: 2009 update. Mol Psychiatry 15: 18-22
290. Uher R, Perroud N, Ng MY et al (2010) Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. Am J Psychiatry 16: 555-564
291. Unschuld PG, Ising M, Erhardt A et al (2007) Polymorphisms in the serotonin receptor gene HTR2A are associated with quantitative traits in panic disorder. Am J Med Genet B Neuropsychiatr Genet 144: 424-429
292. Unschuld PG, Ising M, Erhardt A et al (2008) Polymorphisms in the galanin gene are associated with symptom-severity in female patients suffering from panic disorder. J Affect Disord 105: 177-184
293. Unschuld PG, Ising M, Roeske D et al (2010) Gender-specific association of galanin polymorphisms with HPA-axis dysregulation, symptom severity, and antidepressant treatment response. Neuropsychopharmacology 35: 1583-1592
294. Unschuld PG, Ising M, Specht M et al (2009) Polymorphisms in the GAD2 gene-region are associated with susceptibility for unipolar depression and with a risk factor for anxiety disorders. Am J Med Genet B Neuropsychiatr Genet 150: 1100-1109
295. Velders FP, Kuningas M, Kumari M, Dekker MJ, Uitterlinden AG, Kirschbaum C, Hek K, Hofman A, Verhulst FC, Kivimaki M, Van Duijn CM, Walker BR, Tiemeier H (2011) Genetics of cortisol secretion and depressive symptoms: a candidate gene and genome wide association approach. Psychoneuroendocrinology 36(7): 1053-1061
296. Verhagen M, van der Meij A, van Deurzen PA et al (2010) Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Mol Psychiatry 15: 260-271
297. Vieland VJ, Goodman DW, Chapman T et al (1996) New segregation analysis of panic disorder. Am J Med Genet 67: 147-153
298. Wang KS, Liu XF, Aragam N (2010) A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder. Schizophr Res 124: 192-199
299. Wang Z, Valdes J, Noyes R et al (1998) Possible association of a cholecystokinin promotor polymorphism (CCK-36CT) with panic disorder. Am J Med Genet 81: 228-234
300. Weber H, Kittel-Schneider S, Gessner A, Domschke K, Neuner M, Jacob CP, Buttenschon HN, Boreatti-Hümmer A, Volkert J, Herterich S, Baune BT, Gross-Lesch S, Kopf J, Kreiker S, Nguyen TT, Weissflog L, Arolt V, Mors O, Deckert J, Lesch KP, Reif A (2011) Crossdisorder analysis of bipolar risk genes: further evidence of DGKH as a risk gene for bipolar disorder, but also unipolar depression and adult ADHD. Neuropsychopharmacology 36(10): 2076-2085
301. Weissman MM, Fyer AJ, Haghighi F et al (2000) Potential panic disorder syndrome: clinical and genetic linkage evidence. Am J Med Genet 96: 24-35
302. Wender PH, Kety SS, Rosenthal D et al (1986) Psychiatric disorders in the biological and adoptive families of adopted individuals with affective disorders. Arch Gen Psychiatry 43: 923-929
303. Wessa M, Linke J, Witt SH, Nieratschker V, Esslinger C, Kirsch P, Grimm O, Hennerici MG, Gass A, King AV, Rietschel M (2010) The CACNA1C risk variant for bipolar disorder influences limbic activity. Mol Psychiatry 15(12): 1126-1127
304. Williams HJ, Craddock N, Russo G et al (2011) Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries. Hum Mol Genet 20: 387-391
305. Woo JM, Yoon KS, Choi YH et al (2004) The association between panic disorder and the L/L genotype of catechol-O-methyltransferase. J Psychiatr Res 38: 365-370
306. Woo JM, Yoon KS, Yu BH (2002) Catechol O-methyltransferase genetic polymorphism in panic disorder. Am J Psychiatry 159: 1785-1787
307. Wray NR, Pergadia ML, Blackwood DH, Penninx BW, Gordon SD, Nyholt DR, Ripke S, Macintyre DJ, McGhee KA, MacleanAW, Smit JH, Hottenga JJ, Willemsen G, Middeldorp CM, de Geus EJ, Lewis CM, McGuffin P, Hickie IB, van den Oord EJ, Liu JZ, Macgregor S, McEvoy BP, Byrne EM, Medland SE, Statham DJ, Henders AK, Heath AC, Montgomery GW, Martin NG, Boomsma DI, Madden PA, Sullivan PF (2012) Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned. Mol Psychiatry 17(1): 36-48
308. WTCCC (2007) Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 447: 661-678
309. Xie P, Kranzler HR, Poling J et al (2010) Interaction of FKBP5 with childhood adversity on risk for post-traumatic stress disorder. Neuropsychopharmacology 35: 1684-1692
310. Yasuda S, Kai M, Imai S et al (2009) Diacylglycerol kinase eta augments C-Raf activity and B-Raf/C-Raf heterodimerization. J Biol Chem 284: 29559-29570
311. Yevtushenko OO, Oros MM, Reynolds GP (2010) Early response to selective serotonin reuptake inhibitors in panic disorder is associated with a functional 5-HT1A receptor gene polymorphism. J Affect Disord 123: 308-311
312. Yoon HK, Yang JC, Lee HJ et al (2008) The association between serotonin-related gene polymorphisms and panic disorder. J Anxiety Disord 22: 1529-1534
313. Zeng Z, Wang T, Li T et al (2011) Common SNPs and haplotypes in DGKH are associated with bipolar disorder and schizophrenia in the Chinese Han population. Mol Psychiatry 16: 473-475
314. Zhang D, Cheng L, Qian Y et al (2009a) Singleton deletions throughout the genome increase risk of bipolar disorder. Mol Psychiatry 14: 376-380
315. Zhang Z, Lindpaintner K, Che R et al (2009b) The Val/Met functional polymorphism in COMT confers susceptibility to bipolar disorder: evidence from an association study and a metaanalysis. J Neural Transm 116: 1193-1200
316. Zhou K, Dempfle A, Arcos-Burgos M et al (2008) Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 147B: 1392-1398
317. Zimmerman M, Chelminski I, McDermut W (2002) Major depressive disorder and axis I diagnostic comorbidity. J Clin Psychiatry 63: 187-193
318. Zintzaras E (2006) C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: a meta-analysis of genetic association studies. Psychiatr Genet 16: 105-115
319. Zintzaras E, Sakelaridis N (2007) Is 472G/A catechol-O-methyl-transferase gene polymorphism related to panic disorder? Psychiatr Genet 17: 267-273
320. Zobel A, Schuhmacher A, Jessen F et al (2010) DNA sequence variants of the FKBP5 gene are associated with unipolar depression. Int J Neuropsychopharmacol 13: 649-660
321. Zou YF, Wang F, Feng XL, Li WF, Tian YH, Tao JH, Pan FM, Huang F (2010) Association of DRD2 gene polymorphisms with mood disorders: a meta-analysis. J Affect Disord (in press)